Skip to main content
SpringerLink
Log in

Clinical and experimental research of primary liver cancer in China

  • Original Articles
  • Published:
The Chinese-German Journal of Clinical Oncology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Parkin DM, Pisani P, Perlay J. Estimates of worldwide incidence of eighteen major cancer in 1985. Int J Cancer, 1993, 54: 594.

    Article  CAS  PubMed  Google Scholar 

  2. Wu MC, Chen H, Zhang XH, et al. Primary hepatic carcinoma over 18 years. Chin J Med, 1980, 93(10): 723.

    CAS  Google Scholar 

  3. Zhang XH, Wu MC, Wu BW, et al. Combined therapy with operation and radiation in primary liver cancer. J Med Coll PLA, 1986, 1(2): 170.

    Google Scholar 

  4. Chen H, Wu MC. Rehepatectomy for treating primary liver cancer. Proc CAMS and PUMC, 1989,4(2): 68.

    CAS  Google Scholar 

  5. Tang ZY, Liu KD, Fan Z, et al. Targeting therapy of hepatocellular carcinoma: experimental and clinical studies. Tumor, 1990, 10:241.

    Google Scholar 

  6. Wu MC. Surgical treatment of primary liver cancer: report of 5524 cases. Chin J Surg, 2001, 39:25.

    Google Scholar 

  7. Wu MC. Progress in diagnosis and treatment of primary liver cancer. Chin J Surg, 1998, 36:515.

    Google Scholar 

  8. Bismuth H, Hajro PE, Adam R, et al. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis, 1999, 19(3):311.

    Article  CAS  PubMed  Google Scholar 

  9. Selby R, Kadry Z, Carr B, et al. Liver transplantation for hepatocellular carcinoma. World J Surg, 1995, 19(1):53.

    Article  CAS  PubMed  Google Scholar 

  10. Huang JF, Wang WS. Treatment of irresectable hepatocellular carcinoma with repeated transient dearterialization. Chin J Surg, 1996, 34:522.

    CAS  PubMed  Google Scholar 

  11. Chen H, Wu MC. The choice of treatment for recurrence of primary liver cancer after hepatic resection. Chin J Med, 1997, 77(3): 163.

    CAS  Google Scholar 

  12. Wu MC, Chen H, Yan YQ. Rehepatectomy for primary liver cancer. Sem Surg Oncol, 1993,9:323.

    Article  CAS  Google Scholar 

  13. Cheng HY, Chen D, Xu AM, et al. Influence factors to recurrence of hepatocellular carcinoma after surgical resection. Chin J Cancer Res, 2000, 12(2): 135.

    Article  Google Scholar 

  14. Zhang XH, Wu MC, Chen H, et al. Hepatic artery ligation or operative hepatic arterial embolization for 160 cases of unresectable primary liver cancer. Tumor, 1986,6:185.

    Google Scholar 

  15. Guo YJ, Wu MC, Kong XT, et al. Local immune response in hepatocellular carcinoma and its clinical implication. Clin Med J, 1988, 101(9):685.

    CAS  Google Scholar 

  16. Zhang ZJ, Liu Q, He J, et al. The effect of preoperative transcatheter hepatic arterial chemoembolization disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer, 2000, 89:2606.

    Article  CAS  PubMed  Google Scholar 

  17. Horigome H, Nomura T, Saso K, et al. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am J Gastroenterol, 1999, 94:1914.

    Article  CAS  PubMed  Google Scholar 

  18. Wong WS, Patel SC, Cruz FS, et al. Cryosurgery as a treatment for advanced staged HCC: results, complications and ethanol ablation. Cancer, 1998, 82: 1268.

    Article  CAS  PubMed  Google Scholar 

  19. Chen YQ, Jiang HQ, Gu JR, et al. The status of HBV DNA in human primary liver cancer and peri-tumor tissues and its significance. J Shanghai Med, 1988, 11:63–67.

    Google Scholar 

  20. Shen F, Wang H, Xie TP, et al. Experimental and clinical research of cytolytic T lymphocytes specific for hepatocellular carcinoma. Chin J Surg, 1997, 35:95–99.

    CAS  PubMed  Google Scholar 

  21. Zhang SM, Wu MC, Chen H, et al. The value of glycotidase spectrum in the diagnosis of hepatocellular carcinoma. Chin J Cancer, 1992, 14:143–145.

    CAS  Google Scholar 

  22. Wang Q, Chen ZN, Wang WL, et al. Anti-tumor effects of bispecific monoclonal antibody targeted human monocytes-macrophages on hepatoma cells. Chin J Med, 1996,76:96–99.

    CAS  Google Scholar 

  23. Li BA, Wang HY, Wu MC, et al. Expression of signal-regulatory protein α (SIRPα) in hepatocellular carcinoma. Chin J Cancer, 1998,20:345–347.

    CAS  Google Scholar 

  24. Liu KD, Tang ZY, Yu YQ, et al. Factors influencing the liver cancer recurrence and their significance. Chin J Med, 1996, 76:617.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 200438, Shanghai, China

    Wu Mengchao

Authors
  1. Wu Mengchao
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mengchao, W. Clinical and experimental research of primary liver cancer in China. Chin. -Ger. J. Clin. Oncol. 1, 1–4 (2002). https://doi.org/10.1007/BF02851783

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02851783

Keywords

Search

Navigation